Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy
用于预防艾滋病毒和怀孕的双适应症阴道环中药物成分的表征
基本信息
- 批准号:10697056
- 负责人:
- 金额:$ 45.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAnimal ModelAreaCharacteristicsCollaborationsContractorContractsDapivirineDosage FormsHIVInvestigator-Initiated ResearchLevonorgestrelMorphologyNational Institute of Allergy and Infectious DiseasePharmaceutical PreparationsPregnancyPreventionResourcesServicesTechnologyVaginal Ringmicrobicideparticlepre-clinicalproduct developmentresearch study
项目摘要
The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.
杀微生物剂和生物医学预防综合资源合同的目的是为NIAID提供一套全面的临床前产品开发服务,用于从制药商发起的研究或与外部公司或组织合作中产生的候选产品。承包商应提供:1)临床前填补空白服务; 2)支持产品开发的HIV动物模型; 3)生物分析支持服务; 4)产品制造;以及5)科学和质量/监管支持服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER SILVERA其他文献
PETER SILVERA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER SILVERA', 18)}}的其他基金
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
推进儿科和艾滋病毒预防科学 (RAPPS) 的资源:质量保证/质量控制 (QA/QC) 支持
- 批准号:
10850722 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Expertise in Development of Pediatric Drug Formulations
儿科药物制剂开发的专业知识
- 批准号:
10927009 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
HIV 杀菌剂和生物医学预防的综合资源:NHP 购买和持有
- 批准号:
10875256 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
推进儿科和艾滋病毒预防科学的资源:科学和质量/监管支持服务
- 批准号:
10927010 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
HIV 杀菌剂和生物医学预防的综合资源:NHP 购买和持有
- 批准号:
10630805 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Material Receipt, Storage, Shipping and Inventory
HIV 杀菌剂和生物医学预防的综合资源:材料接收、储存、运输和库存
- 批准号:
10788222 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
Advancing the Development of Pediatric Drug Formulations: Planning and Implementation of a DAIDS-Industry Pediatric Formulation Partnership and Pediatric Drug Formulation Think Tank
推进儿科药物制剂的发展:DAIDS行业儿科制剂合作伙伴关系和儿科药物制剂智库的规划和实施
- 批准号:
10647608 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
Statistical and Pharmacometric Modeling Support for HIV Non-Vaccine Biomedical Prevention Product Development
HIV 非疫苗生物医学预防产品开发的统计和药理学建模支持
- 批准号:
10629146 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials
增强艾滋病毒预防试验中药物依从性的人种学专业知识
- 批准号:
10629147 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
Expertise in Development of Pediatric Drug Formulations
儿科药物制剂开发的专业知识
- 批准号:
10641643 - 财政年份:2022
- 资助金额:
$ 45.51万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 45.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists